Viewing Study NCT00014261


Ignite Creation Date: 2025-12-24 @ 1:00 PM
Ignite Modification Date: 2026-01-22 @ 7:36 AM
Study NCT ID: NCT00014261
Status: COMPLETED
Last Update Posted: 2018-03-30
First Post: 2001-04-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid Tumors
Sponsor: Dartmouth-Hitchcock Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module